These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2427844

  • 21. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
    Keyriläinen O, Uustialo A.
    Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
    [Abstract] [Full Text] [Related]

  • 22. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.
    Atwood JE, Sullivan M, Forbes S, Myers J, Pewen W, Olson HG, Froelicher VF.
    J Am Coll Cardiol; 1987 Aug; 10(2):314-20. PubMed ID: 2885354
    [Abstract] [Full Text] [Related]

  • 23. Management of chronic stable angina with once-daily bisoprolol or atenolol and long-term efficacy of bisoprolol.
    Kohli RS, Lahiri A, Raftery EB.
    J Cardiovasc Pharmacol; 1986 Aug; 8 Suppl 11():S148-53. PubMed ID: 2439787
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of coronary heart disease with the beta-1-receptor blocker celiprolol in a long-term study over a 12-month period].
    Klinger D.
    Wien Med Wochenschr; 1987 Jun 30; 137(12):278-86. PubMed ID: 2887073
    [Abstract] [Full Text] [Related]

  • 25. Clinical performance and therapeutic potential of celiprolol in angina pectoris.
    Soberman JE, Frishman WH.
    J Cardiovasc Pharmacol; 1989 Jun 30; 14 Suppl 7():S9-13. PubMed ID: 2481791
    [Abstract] [Full Text] [Related]

  • 26. Celiprolol in systemic hypertension.
    Frishman WH, Flamenbaum W, Schoenberger J, Schwartz GL, Vidt DG, Neri GS, Greenberg S, Lazar E, Godfrey JC, Stevenson A.
    Am J Cardiol; 1989 Apr 01; 63(12):839-42. PubMed ID: 2522723
    [Abstract] [Full Text] [Related]

  • 27. Effectiveness of bevantolol in the treatment of angina--a placebo-controlled study.
    Farnham DJ.
    Angiology; 1986 Mar 01; 37(3 Pt 2):226-32. PubMed ID: 2871782
    [Abstract] [Full Text] [Related]

  • 28. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U, Zellner SR, Glasser S, Bittar N, Montoro R, Miller AB, Chaitman B, Schulman P, Stahl A, DiBianco R.
    Circulation; 1991 Dec 01; 84(6):2398-408. PubMed ID: 1959195
    [Abstract] [Full Text] [Related]

  • 29. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W, Mitrovic V, Neuss H, Schlepper M, Cocco G, Prager G, Fitscha P, Meisner W.
    J Cardiovasc Pharmacol; 1991 Dec 01; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [Abstract] [Full Text] [Related]

  • 30. A single-blind randomized comparison of the 24-h antianginal efficacy of celiprolol versus atenolol.
    Jackson NC, Lee PS, Taylor SH.
    J Cardiovasc Pharmacol; 1986 Dec 01; 8 Suppl 4():S145-7. PubMed ID: 2427846
    [Abstract] [Full Text] [Related]

  • 31. Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity.
    Rodrigues EA, Lahiri A, Hughes LO, Kohli RS, Whittington JR, Raftery EB.
    Am J Cardiol; 1986 Nov 01; 58(10):916-21. PubMed ID: 2877564
    [Abstract] [Full Text] [Related]

  • 32. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
    Kato K, Niitani H, Kanazawa T, Shimomura K, Toyama S.
    J Cardiovasc Pharmacol; 1986 Nov 01; 8 Suppl 11():S154-9. PubMed ID: 2439788
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
    Kohli RS, Khurmi NS, Kardash MM, Hughes LO, Lahiri A, Raftery EB.
    Eur Heart J; 1985 Oct 01; 6(10):845-50. PubMed ID: 2866960
    [Abstract] [Full Text] [Related]

  • 34. Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.
    Boden WE, Bough EW, Reichman MJ, Rich VB, Young PM, Korr KS, Shulman RS.
    Circulation; 1985 Jun 01; 71(6):1197-205. PubMed ID: 2859931
    [Abstract] [Full Text] [Related]

  • 35. Celiprolol in the treatment of hypertension: a comparison with propranolol.
    Taylor SH, Beattie A, Silke B.
    J Cardiovasc Pharmacol; 1986 Jun 01; 8 Suppl 4():S127-31. PubMed ID: 2427842
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of once daily penbutolol in chronic stable angina. An objective comparison with long-acting propranolol.
    Bowles MJ, Khurmi NS, Bala Subramanian V, Raftery EB.
    Int J Cardiol; 1984 Feb 01; 5(2):131-42. PubMed ID: 6365803
    [Abstract] [Full Text] [Related]

  • 37. Improved left ventricular function during exercise: a comparison of celiprolol and atenolol.
    McLenachan J, Wilson J, Dargie H.
    Am Heart J; 1988 Nov 01; 116(5 Pt 2):1435-6. PubMed ID: 2903655
    [No Abstract] [Full Text] [Related]

  • 38. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U, Ezekowitz M, Fenney L, Chiang YK.
    Circulation; 1994 Aug 01; 90(2):726-34. PubMed ID: 8044941
    [Abstract] [Full Text] [Related]

  • 39. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
    Silke B, Verma SP, Frais MA, Reynolds G, Taylor SH.
    Br J Clin Pharmacol; 1986 Dec 01; 22(6):697-706. PubMed ID: 2882772
    [Abstract] [Full Text] [Related]

  • 40. Nadolol compared to propranolol for treating chronic stable angina pectoris.
    Miller LA, Crawford MH, O'Rourke RA.
    Chest; 1984 Aug 01; 86(2):189-93. PubMed ID: 6146499
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.